ORCHID PHARMA LIMITED

Inactive Instrument

Other languages Orchid Pharma Limited Bombay S.E.

Equities

524372

INE191A01019

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Orchid Pharma Gets Indian Regulator's Nod for Enmetazobactam	06-06
Orchid Pharma Receives DCGI Approval for Its First Invented and Made-In-India Antibiotic Drug Combination of Cefepime and Enmetazobactam	06-06
Orchid Pharma Limited Appoints Shubha Singh as Additional Director	05-23
Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-23
Orchid Pharma Limited Announces Resignation of Mudit Tandon as Independent Director	04-12
Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention	02-23
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-08
European Medicines Agency Grants Approval for Orchid Pharma's 'Exblifep'	01-30
Orchid Pharma Limited Appoints Kapil Dayya as Company Secretary & Compliance Officer	12-16
Orchid Pharma Limited Announces Resignation of Marina Peter as Company Secretary and Compliance Officer	12-14
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-04
Orchid Pharma Limited Approves the Appointment of Mr. Arjun Dhanuka as Additional Director (In Capacity of Non-Executive & Non-Independent)	23-10-20
Orchid Pharma Limited Enters into Manufacturing Sub License Agreement with Global Antibiotic Research & Development Partnership	23-09-12
Orchid Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10
Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-10
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-09
Orchid Pharma Limited Announces Demise of Arun Kumar Dhanuka, Non-Executive & Non-Independent Director	23-02-01
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer